EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 53 / No 1 (March 2021) J Extra Corpor Technol, 53 1 (2021) 40-45 References
Free Access
Issue
J Extra Corpor Technol
Volume 53, Number 1, March 2021
Page(s) 40 - 45
DOI https://doi.org/10.1051/ject/202153040
Published online 15 March 2021
  1. Barbaro RP, Paden ML, Guner YS, et al. . Pediatric extracorporeal life support organization registry international report 2016. ASAIO J. 2017;63:456–63. [CrossRef] [PubMed] [Google Scholar]
  2. ELSO. 2018. Pediatric Cardiac Failure, Extracorporeal Life Support Organization, Ann Arbor, MI. Available at: https://www.elso.org/Portals/0/IGD/Archive/FileManager/ELSO_Reformatted_2018.02.23.pdf. Accessed December 1, 2018. [Google Scholar]
  3. Ray MJ, Marsh NA, Hawson GA, Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagul Fibrinolysis. 1994;5:679–85. [CrossRef] [PubMed] [Google Scholar]
  4. Levy JH, Koster A, Quinones QJ, et al. . Antifibrinolytic therapy and perioperative considerations. Anesthesiol J Am Soc Anesthesiol. 2018;128:657–70. [Google Scholar]
  5. Koster A, Faraoni D, Levy JH. Antifibrinolytic therapy for cardiac surgery: An update. Anesthesiology. 2015;123:214–21. [CrossRef] [PubMed] [Google Scholar]
  6. Horwitz JR, Cofer BR, Warner BW, et al. . A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO. J Pediatr Surg. 1998;33:1610–3. [CrossRef] [PubMed] [Google Scholar]
  7. Wilson JM, BowerLK, Fackler JC, et al. . Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatr Surg. 1993;28:536–40; discussion 540–1. [CrossRef] [PubMed] [Google Scholar]
  8. Downard CD, Betit P, Chang RW, et al. . Impact of AMICAR on hemorrhagic complications of ECMO: A ten-year review. J Pediatr Surg. 2003;38:1212–6. [CrossRef] [PubMed] [Google Scholar]
  9. Lin CY, Shuhaiber JH, Loyola H, et al. . The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. PLoS One. 2015;10:e0126514. [CrossRef] [PubMed] [Google Scholar]
  10. Buckley LF, Reardon DP, Camp PC, et al. . Aminocaproic acid for the management of bleeding in patients on extracorporeal membrane oxygenation: Four adult case reports and a review of the literature. Heart Lung. 2016;45:232–6. [CrossRef] [PubMed] [Google Scholar]
  11. Polito A, BarrettCS, RycusPT, et al. . Neurologic injury in neonates with congenital heart disease during extracorporeal membrane oxygenation: An analysis of extracorporeal life support organization registry data. ASAIO J. 2015;61:43–8. [CrossRef] [PubMed] [Google Scholar]
  12. Polito A, Barrett CS, Wypij D, et al. . Neurologic complications in neonates supported with extracorporeal membrane oxygenation. An analysis of ELSO registry data. Intensive Care Med. 2013;39:1594–601. [CrossRef] [PubMed] [Google Scholar]
  13. Okochi S, Shakoor A, Barton S, et al. . Prevalence of seizures in pediatric extracorporeal membrane oxygenation patients as measured by continuous Electroencephalography. Pediatr Crit Care Med. 2018;19:1162–7. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.